Preventing hypertensive kidney disease: The critical role of combination therapy

American Journal of Hypertension

Volumn 18, Issue 4 SUPPL., 2005, Pages 93-94

  Bakris, George L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE COURSE; HUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION;

EID: 17444380840     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.11.016     Document Type: Conference Paper

References (7)

1. National Kidney Foundation K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease Am J Kidney Dis 43 Suppl 1 2004 S1 S290
2. L. Raij The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease Am J Hypertens 18 Suppl 2005 95S 99S
3. M.R. Weir The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease Am J Hypertens 18 Suppl 2005 100S 105S
4. K.A. Jamerson, G.L. Bakris, C.-C. Wun, B. Dahlöf, M. Lefkowitz, S. Manfreda, B. Pitt, E.J. Velazquez, M.A. Weber Rationale and design of the Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH) trial. The first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension Am J Hypertens 17 2004 793 801
5. K.A. Jamerson Preventing chronic kidney disease in special populations Am J Hypertens 18 Suppl 2005 106S 111S
6. J.T. Wright Jr, G. Bakris, T. Greene, L.Y. Agodoa, L.J. Appel, J. Charleston, D. Cheek, J.G. Douglas-Baltimore, J. Gassman, R. Glassock, L. Hebert, K. Jamerson, J. Lewis, R.A. Phillips, R.D. Toto, J.P. Middleton, S.G. Rostand African American Study of Kidney Disease and Hypertension Study Group Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease results from the AASK trial JAMA 288 2002 2421 2431
7. G.L. Bakris Protecting renal function in the hypertensive patient clinical guidelines Am J Hypertens 18 Suppl 2005 112S 119S